Business
Pfizer’s COVID-19 vaccine found to be highly effective for adolescents – ABC News
A study of the Pfizer vaccine shows the jab is highly effective in adolescents aged 12-15 years old, recording higher levels of antibodies than in young adults.
Pfizer and BioNTech’s COVID-19 vaccine is safe, effective and produces robust antibody responses in 12- to 15-year olds, according to a trial run by the companies.
Key points:
- No cases were detected in the trial group who got the vaccine, compared with 18 in the placebo group
- The trial participants experienced the same side-effects that had been noted in adults
- Pfizer hopes to begin vaccinating US teenagers before the new school year
The data from a clinical trial, which puts the shot ahead of other…
Continue Reading
-
Noosa News23 hours agoInside the final hours before Australian lawyer Christopher Saines died in Thai massage parlour
-
General21 hours agoGerman backpacker Carolina Wilga found alive in WA’s outback
-
Business23 hours agoHow $1,000 a month in this ASX ETF could turn into $500,000
-
Noosa News23 hours agoGrow it local | Noosa Today